Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1553023

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1553023

Global Medicine Pipeline Market Insights, Forecast to 2030

PUBLISHED:
PAGES: 134 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Medicine Pipeline Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Medicine Pipeline Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 Innovative Drugs
    • 1.2.3 Generic Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Medicine Pipeline Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Pharmaceutical Industry
    • 1.3.3 Biotechnology
    • 1.3.4 Public Health
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Medicine Pipeline Market Perspective (2019-2030)
  • 2.2 Global Medicine Pipeline Growth Trends by Region
    • 2.2.1 Global Medicine Pipeline Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Medicine Pipeline Historic Market Size by Region (2019-2024)
    • 2.2.3 Medicine Pipeline Forecasted Market Size by Region (2025-2030)
  • 2.3 Medicine Pipeline Market Dynamics
    • 2.3.1 Medicine Pipeline Industry Trends
    • 2.3.2 Medicine Pipeline Market Drivers
    • 2.3.3 Medicine Pipeline Market Challenges
    • 2.3.4 Medicine Pipeline Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Medicine Pipeline by Players
    • 3.1.1 Global Medicine Pipeline Revenue by Players (2019-2024)
    • 3.1.2 Global Medicine Pipeline Revenue Market Share by Players (2019-2024)
  • 3.2 Global Medicine Pipeline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Medicine Pipeline, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Medicine Pipeline Market Concentration Ratio
    • 3.4.1 Global Medicine Pipeline Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Medicine Pipeline Revenue in 2023
  • 3.5 Global Key Players of Medicine Pipeline Head office and Area Served
  • 3.6 Global Key Players of Medicine Pipeline, Product and Application
  • 3.7 Global Key Players of Medicine Pipeline, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Medicine Pipeline Breakdown Data by Type

  • 4.1 Global Medicine Pipeline Historic Market Size by Type (2019-2024)
  • 4.2 Global Medicine Pipeline Forecasted Market Size by Type (2025-2030)

5 Medicine Pipeline Breakdown Data by Application

  • 5.1 Global Medicine Pipeline Historic Market Size by Application (2019-2024)
  • 5.2 Global Medicine Pipeline Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Medicine Pipeline Market Size (2019-2030)
  • 6.2 North America Medicine Pipeline Market Size by Type
    • 6.2.1 North America Medicine Pipeline Market Size by Type (2019-2024)
    • 6.2.2 North America Medicine Pipeline Market Size by Type (2025-2030)
    • 6.2.3 North America Medicine Pipeline Market Share by Type (2019-2030)
  • 6.3 North America Medicine Pipeline Market Size by Application
    • 6.3.1 North America Medicine Pipeline Market Size by Application (2019-2024)
    • 6.3.2 North America Medicine Pipeline Market Size by Application (2025-2030)
    • 6.3.3 North America Medicine Pipeline Market Share by Application (2019-2030)
  • 6.4 North America Medicine Pipeline Market Size by Country
    • 6.4.1 North America Medicine Pipeline Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Medicine Pipeline Market Size by Country (2019-2024)
    • 6.4.3 North America Medicine Pipeline Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Medicine Pipeline Market Size (2019-2030)
  • 7.2 Europe Medicine Pipeline Market Size by Type
    • 7.2.1 Europe Medicine Pipeline Market Size by Type (2019-2024)
    • 7.2.2 Europe Medicine Pipeline Market Size by Type (2025-2030)
    • 7.2.3 Europe Medicine Pipeline Market Share by Type (2019-2030)
  • 7.3 Europe Medicine Pipeline Market Size by Application
    • 7.3.1 Europe Medicine Pipeline Market Size by Application (2019-2024)
    • 7.3.2 Europe Medicine Pipeline Market Size by Application (2025-2030)
    • 7.3.3 Europe Medicine Pipeline Market Share by Application (2019-2030)
  • 7.4 Europe Medicine Pipeline Market Size by Country
    • 7.4.1 Europe Medicine Pipeline Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Medicine Pipeline Market Size by Country (2019-2024)
    • 7.4.3 Europe Medicine Pipeline Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia
    • 7.4.9 Nordic Countries

8 China

  • 8.1 China Medicine Pipeline Market Size (2019-2030)
  • 8.2 China Medicine Pipeline Market Size by Type
    • 8.2.1 China Medicine Pipeline Market Size by Type (2019-2024)
    • 8.2.2 China Medicine Pipeline Market Size by Type (2025-2030)
    • 8.2.3 China Medicine Pipeline Market Share by Type (2019-2030)
  • 8.3 China Medicine Pipeline Market Size by Application
    • 8.3.1 China Medicine Pipeline Market Size by Application (2019-2024)
    • 8.3.2 China Medicine Pipeline Market Size by Application (2025-2030)
    • 8.3.3 China Medicine Pipeline Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Medicine Pipeline Market Size (2019-2030)
  • 9.2 Asia Medicine Pipeline Market Size by Type
    • 9.2.1 Asia Medicine Pipeline Market Size by Type (2019-2024)
    • 9.2.2 Asia Medicine Pipeline Market Size by Type (2025-2030)
    • 9.2.3 Asia Medicine Pipeline Market Share by Type (2019-2030)
  • 9.3 Asia Medicine Pipeline Market Size by Application
    • 9.3.1 Asia Medicine Pipeline Market Size by Application (2019-2024)
    • 9.3.2 Asia Medicine Pipeline Market Size by Application (2025-2030)
    • 9.3.3 Asia Medicine Pipeline Market Share by Application (2019-2030)
  • 9.4 Asia Medicine Pipeline Market Size by Region
    • 9.4.1 Asia Medicine Pipeline Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Medicine Pipeline Market Size by Region (2019-2024)
    • 9.4.3 Asia Medicine Pipeline Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Medicine Pipeline Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Medicine Pipeline Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Medicine Pipeline Introduction
    • 11.1.4 Roche Revenue in Medicine Pipeline Business (2019-2024)
    • 11.1.5 Roche Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Medicine Pipeline Introduction
    • 11.2.4 Pfizer Revenue in Medicine Pipeline Business (2019-2024)
    • 11.2.5 Pfizer Recent Development
  • 11.3 AstraZeneca
    • 11.3.1 AstraZeneca Company Details
    • 11.3.2 AstraZeneca Business Overview
    • 11.3.3 AstraZeneca Medicine Pipeline Introduction
    • 11.3.4 AstraZeneca Revenue in Medicine Pipeline Business (2019-2024)
    • 11.3.5 AstraZeneca Recent Development
  • 11.4 Eli Lilly
    • 11.4.1 Eli Lilly Company Details
    • 11.4.2 Eli Lilly Business Overview
    • 11.4.3 Eli Lilly Medicine Pipeline Introduction
    • 11.4.4 Eli Lilly Revenue in Medicine Pipeline Business (2019-2024)
    • 11.4.5 Eli Lilly Recent Development
  • 11.5 Bristol Myers Squibb
    • 11.5.1 Bristol Myers Squibb Company Details
    • 11.5.2 Bristol Myers Squibb Business Overview
    • 11.5.3 Bristol Myers Squibb Medicine Pipeline Introduction
    • 11.5.4 Bristol Myers Squibb Revenue in Medicine Pipeline Business (2019-2024)
    • 11.5.5 Bristol Myers Squibb Recent Development
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Business Overview
    • 11.6.3 Novartis Medicine Pipeline Introduction
    • 11.6.4 Novartis Revenue in Medicine Pipeline Business (2019-2024)
    • 11.6.5 Novartis Recent Development
  • 11.7 Johnson & Johnson
    • 11.7.1 Johnson & Johnson Company Details
    • 11.7.2 Johnson & Johnson Business Overview
    • 11.7.3 Johnson & Johnson Medicine Pipeline Introduction
    • 11.7.4 Johnson & Johnson Revenue in Medicine Pipeline Business (2019-2024)
    • 11.7.5 Johnson & Johnson Recent Development
  • 11.8 Jiangsu Hengrui Pharmaceuticals
    • 11.8.1 Jiangsu Hengrui Pharmaceuticals Company Details
    • 11.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
    • 11.8.3 Jiangsu Hengrui Pharmaceuticals Medicine Pipeline Introduction
    • 11.8.4 Jiangsu Hengrui Pharmaceuticals Revenue in Medicine Pipeline Business (2019-2024)
    • 11.8.5 Jiangsu Hengrui Pharmaceuticals Recent Development
  • 11.9 Merck
    • 11.9.1 Merck Company Details
    • 11.9.2 Merck Business Overview
    • 11.9.3 Merck Medicine Pipeline Introduction
    • 11.9.4 Merck Revenue in Medicine Pipeline Business (2019-2024)
    • 11.9.5 Merck Recent Development
  • 11.10 Sanofi
    • 11.10.1 Sanofi Company Details
    • 11.10.2 Sanofi Business Overview
    • 11.10.3 Sanofi Medicine Pipeline Introduction
    • 11.10.4 Sanofi Revenue in Medicine Pipeline Business (2019-2024)
    • 11.10.5 Sanofi Recent Development
  • 11.11 APC
    • 11.11.1 APC Company Details
    • 11.11.2 APC Business Overview
    • 11.11.3 APC Medicine Pipeline Introduction
    • 11.11.4 APC Revenue in Medicine Pipeline Business (2019-2024)
    • 11.11.5 APC Recent Development
  • 11.12 AbbVie
    • 11.12.1 AbbVie Company Details
    • 11.12.2 AbbVie Business Overview
    • 11.12.3 AbbVie Medicine Pipeline Introduction
    • 11.12.4 AbbVie Revenue in Medicine Pipeline Business (2019-2024)
    • 11.12.5 AbbVie Recent Development
  • 11.13 Moderna
    • 11.13.1 Moderna Company Details
    • 11.13.2 Moderna Business Overview
    • 11.13.3 Moderna Medicine Pipeline Introduction
    • 11.13.4 Moderna Revenue in Medicine Pipeline Business (2019-2024)
    • 11.13.5 Moderna Recent Development
  • 11.14 Prime Medicine
    • 11.14.1 Prime Medicine Company Details
    • 11.14.2 Prime Medicine Business Overview
    • 11.14.3 Prime Medicine Medicine Pipeline Introduction
    • 11.14.4 Prime Medicine Revenue in Medicine Pipeline Business (2019-2024)
    • 11.14.5 Prime Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Medicine Pipeline Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 Innovative Drugs
    • 1.2.3 Generic Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Medicine Pipeline Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Pharmaceutical Industry
    • 1.3.3 Biotechnology
    • 1.3.4 Public Health
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Medicine Pipeline Market Perspective (2019-2030)
  • 2.2 Global Medicine Pipeline Growth Trends by Region
    • 2.2.1 Global Medicine Pipeline Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Medicine Pipeline Historic Market Size by Region (2019-2024)
    • 2.2.3 Medicine Pipeline Forecasted Market Size by Region (2025-2030)
  • 2.3 Medicine Pipeline Market Dynamics
    • 2.3.1 Medicine Pipeline Industry Trends
    • 2.3.2 Medicine Pipeline Market Drivers
    • 2.3.3 Medicine Pipeline Market Challenges
    • 2.3.4 Medicine Pipeline Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Medicine Pipeline by Players
    • 3.1.1 Global Medicine Pipeline Revenue by Players (2019-2024)
    • 3.1.2 Global Medicine Pipeline Revenue Market Share by Players (2019-2024)
  • 3.2 Global Medicine Pipeline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Medicine Pipeline, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Medicine Pipeline Market Concentration Ratio
    • 3.4.1 Global Medicine Pipeline Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Medicine Pipeline Revenue in 2023
  • 3.5 Global Key Players of Medicine Pipeline Head office and Area Served
  • 3.6 Global Key Players of Medicine Pipeline, Product and Application
  • 3.7 Global Key Players of Medicine Pipeline, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Medicine Pipeline Breakdown Data by Type

  • 4.1 Global Medicine Pipeline Historic Market Size by Type (2019-2024)
  • 4.2 Global Medicine Pipeline Forecasted Market Size by Type (2025-2030)

5 Medicine Pipeline Breakdown Data by Application

  • 5.1 Global Medicine Pipeline Historic Market Size by Application (2019-2024)
  • 5.2 Global Medicine Pipeline Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Medicine Pipeline Market Size (2019-2030)
  • 6.2 North America Medicine Pipeline Market Size by Type
    • 6.2.1 North America Medicine Pipeline Market Size by Type (2019-2024)
    • 6.2.2 North America Medicine Pipeline Market Size by Type (2025-2030)
    • 6.2.3 North America Medicine Pipeline Market Share by Type (2019-2030)
  • 6.3 North America Medicine Pipeline Market Size by Application
    • 6.3.1 North America Medicine Pipeline Market Size by Application (2019-2024)
    • 6.3.2 North America Medicine Pipeline Market Size by Application (2025-2030)
    • 6.3.3 North America Medicine Pipeline Market Share by Application (2019-2030)
  • 6.4 North America Medicine Pipeline Market Size by Country
    • 6.4.1 North America Medicine Pipeline Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Medicine Pipeline Market Size by Country (2019-2024)
    • 6.4.3 North America Medicine Pipeline Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Medicine Pipeline Market Size (2019-2030)
  • 7.2 Europe Medicine Pipeline Market Size by Type
    • 7.2.1 Europe Medicine Pipeline Market Size by Type (2019-2024)
    • 7.2.2 Europe Medicine Pipeline Market Size by Type (2025-2030)
    • 7.2.3 Europe Medicine Pipeline Market Share by Type (2019-2030)
  • 7.3 Europe Medicine Pipeline Market Size by Application
    • 7.3.1 Europe Medicine Pipeline Market Size by Application (2019-2024)
    • 7.3.2 Europe Medicine Pipeline Market Size by Application (2025-2030)
    • 7.3.3 Europe Medicine Pipeline Market Share by Application (2019-2030)
  • 7.4 Europe Medicine Pipeline Market Size by Country
    • 7.4.1 Europe Medicine Pipeline Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Medicine Pipeline Market Size by Country (2019-2024)
    • 7.4.3 Europe Medicine Pipeline Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia
    • 7.4.9 Nordic Countries

8 China

  • 8.1 China Medicine Pipeline Market Size (2019-2030)
  • 8.2 China Medicine Pipeline Market Size by Type
    • 8.2.1 China Medicine Pipeline Market Size by Type (2019-2024)
    • 8.2.2 China Medicine Pipeline Market Size by Type (2025-2030)
    • 8.2.3 China Medicine Pipeline Market Share by Type (2019-2030)
  • 8.3 China Medicine Pipeline Market Size by Application
    • 8.3.1 China Medicine Pipeline Market Size by Application (2019-2024)
    • 8.3.2 China Medicine Pipeline Market Size by Application (2025-2030)
    • 8.3.3 China Medicine Pipeline Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Medicine Pipeline Market Size (2019-2030)
  • 9.2 Asia Medicine Pipeline Market Size by Type
    • 9.2.1 Asia Medicine Pipeline Market Size by Type (2019-2024)
    • 9.2.2 Asia Medicine Pipeline Market Size by Type (2025-2030)
    • 9.2.3 Asia Medicine Pipeline Market Share by Type (2019-2030)
  • 9.3 Asia Medicine Pipeline Market Size by Application
    • 9.3.1 Asia Medicine Pipeline Market Size by Application (2019-2024)
    • 9.3.2 Asia Medicine Pipeline Market Size by Application (2025-2030)
    • 9.3.3 Asia Medicine Pipeline Market Share by Application (2019-2030)
  • 9.4 Asia Medicine Pipeline Market Size by Region
    • 9.4.1 Asia Medicine Pipeline Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Medicine Pipeline Market Size by Region (2019-2024)
    • 9.4.3 Asia Medicine Pipeline Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Medicine Pipeline Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Medicine Pipeline Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Medicine Pipeline Introduction
    • 11.1.4 Roche Revenue in Medicine Pipeline Business (2019-2024)
    • 11.1.5 Roche Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Medicine Pipeline Introduction
    • 11.2.4 Pfizer Revenue in Medicine Pipeline Business (2019-2024)
    • 11.2.5 Pfizer Recent Development
  • 11.3 AstraZeneca
    • 11.3.1 AstraZeneca Company Details
    • 11.3.2 AstraZeneca Business Overview
    • 11.3.3 AstraZeneca Medicine Pipeline Introduction
    • 11.3.4 AstraZeneca Revenue in Medicine Pipeline Business (2019-2024)
    • 11.3.5 AstraZeneca Recent Development
  • 11.4 Eli Lilly
    • 11.4.1 Eli Lilly Company Details
    • 11.4.2 Eli Lilly Business Overview
    • 11.4.3 Eli Lilly Medicine Pipeline Introduction
    • 11.4.4 Eli Lilly Revenue in Medicine Pipeline Business (2019-2024)
    • 11.4.5 Eli Lilly Recent Development
  • 11.5 Bristol Myers Squibb
    • 11.5.1 Bristol Myers Squibb Company Details
    • 11.5.2 Bristol Myers Squibb Business Overview
    • 11.5.3 Bristol Myers Squibb Medicine Pipeline Introduction
    • 11.5.4 Bristol Myers Squibb Revenue in Medicine Pipeline Business (2019-2024)
    • 11.5.5 Bristol Myers Squibb Recent Development
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Business Overview
    • 11.6.3 Novartis Medicine Pipeline Introduction
    • 11.6.4 Novartis Revenue in Medicine Pipeline Business (2019-2024)
    • 11.6.5 Novartis Recent Development
  • 11.7 Johnson & Johnson
    • 11.7.1 Johnson & Johnson Company Details
    • 11.7.2 Johnson & Johnson Business Overview
    • 11.7.3 Johnson & Johnson Medicine Pipeline Introduction
    • 11.7.4 Johnson & Johnson Revenue in Medicine Pipeline Business (2019-2024)
    • 11.7.5 Johnson & Johnson Recent Development
  • 11.8 Jiangsu Hengrui Pharmaceuticals
    • 11.8.1 Jiangsu Hengrui Pharmaceuticals Company Details
    • 11.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
    • 11.8.3 Jiangsu Hengrui Pharmaceuticals Medicine Pipeline Introduction
    • 11.8.4 Jiangsu Hengrui Pharmaceuticals Revenue in Medicine Pipeline Business (2019-2024)
    • 11.8.5 Jiangsu Hengrui Pharmaceuticals Recent Development
  • 11.9 Merck
    • 11.9.1 Merck Company Details
    • 11.9.2 Merck Business Overview
    • 11.9.3 Merck Medicine Pipeline Introduction
    • 11.9.4 Merck Revenue in Medicine Pipeline Business (2019-2024)
    • 11.9.5 Merck Recent Development
  • 11.10 Sanofi
    • 11.10.1 Sanofi Company Details
    • 11.10.2 Sanofi Business Overview
    • 11.10.3 Sanofi Medicine Pipeline Introduction
    • 11.10.4 Sanofi Revenue in Medicine Pipeline Business (2019-2024)
    • 11.10.5 Sanofi Recent Development
  • 11.11 APC
    • 11.11.1 APC Company Details
    • 11.11.2 APC Business Overview
    • 11.11.3 APC Medicine Pipeline Introduction
    • 11.11.4 APC Revenue in Medicine Pipeline Business (2019-2024)
    • 11.11.5 APC Recent Development
  • 11.12 AbbVie
    • 11.12.1 AbbVie Company Details
    • 11.12.2 AbbVie Business Overview
    • 11.12.3 AbbVie Medicine Pipeline Introduction
    • 11.12.4 AbbVie Revenue in Medicine Pipeline Business (2019-2024)
    • 11.12.5 AbbVie Recent Development
  • 11.13 Moderna
    • 11.13.1 Moderna Company Details
    • 11.13.2 Moderna Business Overview
    • 11.13.3 Moderna Medicine Pipeline Introduction
    • 11.13.4 Moderna Revenue in Medicine Pipeline Business (2019-2024)
    • 11.13.5 Moderna Recent Development
  • 11.14 Prime Medicine
    • 11.14.1 Prime Medicine Company Details
    • 11.14.2 Prime Medicine Business Overview
    • 11.14.3 Prime Medicine Medicine Pipeline Introduction
    • 11.14.4 Prime Medicine Revenue in Medicine Pipeline Business (2019-2024)
    • 11.14.5 Prime Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer

List of Tables

Table 1. Global Medicine Pipeline Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Innovative Drugs

Table 3. Key Players of Generic Drugs

Table 4. Global Medicine Pipeline Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Medicine Pipeline Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Medicine Pipeline Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Medicine Pipeline Market Share by Region (2019-2024)

Table 8. Global Medicine Pipeline Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Medicine Pipeline Market Share by Region (2025-2030)

Table 10. Medicine Pipeline Market Trends

Table 11. Medicine Pipeline Market Drivers

Table 12. Medicine Pipeline Market Challenges

Table 13. Medicine Pipeline Market Restraints

Table 14. Global Medicine Pipeline Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Medicine Pipeline Market Share by Players (2019-2024)

Table 16. Global Top Medicine Pipeline Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine Pipeline as of 2023)

Table 17. Global Medicine Pipeline Industry Ranking 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Medicine Pipeline Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Medicine Pipeline, Headquarters and Area Served

Table 20. Global Key Players of Medicine Pipeline, Product and Application

Table 21. Global Key Players of Medicine Pipeline, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Medicine Pipeline Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Medicine Pipeline Revenue Market Share by Type (2019-2024)

Table 25. Global Medicine Pipeline Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Medicine Pipeline Revenue Market Share by Type (2025-2030)

Table 27. Global Medicine Pipeline Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Medicine Pipeline Revenue Market Share by Application (2019-2024)

Table 29. Global Medicine Pipeline Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Medicine Pipeline Revenue Market Share by Application (2025-2030)

Table 31. North America Medicine Pipeline Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Medicine Pipeline Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Medicine Pipeline Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Medicine Pipeline Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Medicine Pipeline Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Medicine Pipeline Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Medicine Pipeline Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Medicine Pipeline Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Medicine Pipeline Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Medicine Pipeline Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Medicine Pipeline Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Medicine Pipeline Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Medicine Pipeline Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Medicine Pipeline Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Medicine Pipeline Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Medicine Pipeline Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Medicine Pipeline Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Medicine Pipeline Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Medicine Pipeline Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Medicine Pipeline Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Medicine Pipeline Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Medicine Pipeline Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Medicine Pipeline Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Medicine Pipeline Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Medicine Pipeline Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Medicine Pipeline Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Medicine Pipeline Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Medicine Pipeline Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Medicine Pipeline Market Size by Country (2025-2030) & (US$ Million)

Table 63. Roche Company Details

Table 64. Roche Business Overview

Table 65. Roche Medicine Pipeline Product

Table 66. Roche Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 67. Roche Recent Development

Table 68. Pfizer Company Details

Table 69. Pfizer Business Overview

Table 70. Pfizer Medicine Pipeline Product

Table 71. Pfizer Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 72. Pfizer Recent Development

Table 73. AstraZeneca Company Details

Table 74. AstraZeneca Business Overview

Table 75. AstraZeneca Medicine Pipeline Product

Table 76. AstraZeneca Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 77. AstraZeneca Recent Development

Table 78. Eli Lilly Company Details

Table 79. Eli Lilly Business Overview

Table 80. Eli Lilly Medicine Pipeline Product

Table 81. Eli Lilly Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 82. Eli Lilly Recent Development

Table 83. Bristol Myers Squibb Company Details

Table 84. Bristol Myers Squibb Business Overview

Table 85. Bristol Myers Squibb Medicine Pipeline Product

Table 86. Bristol Myers Squibb Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 87. Bristol Myers Squibb Recent Development

Table 88. Novartis Company Details

Table 89. Novartis Business Overview

Table 90. Novartis Medicine Pipeline Product

Table 91. Novartis Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 92. Novartis Recent Development

Table 93. Johnson & Johnson Company Details

Table 94. Johnson & Johnson Business Overview

Table 95. Johnson & Johnson Medicine Pipeline Product

Table 96. Johnson & Johnson Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 97. Johnson & Johnson Recent Development

Table 98. Jiangsu Hengrui Pharmaceuticals Company Details

Table 99. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 100. Jiangsu Hengrui Pharmaceuticals Medicine Pipeline Product

Table 101. Jiangsu Hengrui Pharmaceuticals Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 102. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 103. Merck Company Details

Table 104. Merck Business Overview

Table 105. Merck Medicine Pipeline Product

Table 106. Merck Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 107. Merck Recent Development

Table 108. Sanofi Company Details

Table 109. Sanofi Business Overview

Table 110. Sanofi Medicine Pipeline Product

Table 111. Sanofi Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 112. Sanofi Recent Development

Table 113. APC Company Details

Table 114. APC Business Overview

Table 115. APC Medicine Pipeline Product

Table 116. APC Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 117. APC Recent Development

Table 118. AbbVie Company Details

Table 119. AbbVie Business Overview

Table 120. AbbVie Medicine Pipeline Product

Table 121. AbbVie Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 122. AbbVie Recent Development

Table 123. Moderna Company Details

Table 124. Moderna Business Overview

Table 125. Moderna Medicine Pipeline Product

Table 126. Moderna Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 127. Moderna Recent Development

Table 128. Prime Medicine Company Details

Table 129. Prime Medicine Business Overview

Table 130. Prime Medicine Medicine Pipeline Product

Table 131. Prime Medicine Revenue in Medicine Pipeline Business (2019-2024) & (US$ Million)

Table 132. Prime Medicine Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Medicine Pipeline Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Medicine Pipeline Market Share by Type: 2023 VS 2030

Figure 3. Innovative Drugs Features

Figure 4. Generic Drugs Features

Figure 5. Global Medicine Pipeline Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Medicine Pipeline Market Share by Application: 2023 VS 2030

Figure 7. Pharmaceutical Industry Case Studies

Figure 8. Biotechnology Case Studies

Figure 9. Public Health Case Studies

Figure 10. Others Case Studies

Figure 11. Medicine Pipeline Report Years Considered

Figure 12. Global Medicine Pipeline Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Medicine Pipeline Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Medicine Pipeline Market Share by Region: 2023 VS 2030

Figure 15. Global Medicine Pipeline Market Share by Players in 2023

Figure 16. Global Top Medicine Pipeline Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine Pipeline as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Medicine Pipeline Revenue in 2023

Figure 18. North America Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Medicine Pipeline Market Share by Type (2019-2030)

Figure 20. North America Medicine Pipeline Market Share by Application (2019-2030)

Figure 21. North America Medicine Pipeline Market Share by Country (2019-2030)

Figure 22. United States Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Medicine Pipeline Market Share by Type (2019-2030)

Figure 26. Europe Medicine Pipeline Market Share by Application (2019-2030)

Figure 27. Europe Medicine Pipeline Market Share by Country (2019-2030)

Figure 28. Germany Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Medicine Pipeline Market Share by Type (2019-2030)

Figure 36. China Medicine Pipeline Market Share by Application (2019-2030)

Figure 37. Asia Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia Medicine Pipeline Market Share by Type (2019-2030)

Figure 39. Asia Medicine Pipeline Market Share by Application (2019-2030)

Figure 40. Asia Medicine Pipeline Market Share by Region (2019-2030)

Figure 41. Japan Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Medicine Pipeline Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Medicine Pipeline Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Medicine Pipeline Market Share by Country (2019-2030)

Figure 51. Brazil Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Medicine Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Roche Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 59. AstraZeneca Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 60. Eli Lilly Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 61. Bristol Myers Squibb Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 62. Novartis Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 63. Johnson & Johnson Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 64. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 65. Merck Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 66. Sanofi Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 67. APC Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 68. AbbVie Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 69. Moderna Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 70. Prime Medicine Revenue Growth Rate in Medicine Pipeline Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!